Identify actionable biomarkers and their impact on non-small-cell lung cancer (NSCLC)
Integrate recommended approaches to biomarker testing into the management of patients with NSCLC
Utilize the results of biomarker testing to identify optimal treatment strategies for patients with advanced NSCLC
Rasheda Persinger, MSN, AGNP-C, AOCNP
Medical Oncology Lead Nurse Practitioner
Sidney Kimmel Cancer Center Sibley Memorial Hospital
Johns Hopkins System
Rasheda Persinger, MSN, AGNP-C, AOCNP: consultant/advisor/speaker: AstraZeneca, Guardant Health.